Description
Product details
TELMISTRUM CH 40 Telmisartan (40mg), Chlorthalidone (12.5mg) Telmisartan and Chlorthalidone are medications that can be used together for the management of hypertension (high blood pressure). TELMISTRUM CH 40 leverages the complementary mechanisms of action of each drug to effectively lower blood pressure, which can reduce the risk of cardiovascular events such as heart attacks and strokes. Here's a brief overview of each component: Telmisartan Telmisartan is an angiotensin II receptor blocker (ARB). It works by inhibiting the action of angiotensin II, a hormone that causes blood vessels to constrict. By blocking the receptors that angiotensin II acts on, Telmisartan causes blood vessels to relax and widen, which lowers blood pressure and improves blood flow. ARBs are known for their protective effects on the kidneys and are often prescribed for patients with diabetes or kidney disease, in addition to those with hypertension. Chlorthalidone Chlorthalidone is a thiazide-like diuretic, sometimes referred to as a water pill. It helps to reduce blood pressure by removing excess fluid and sodium from the body through the urine. This action decreases blood volume, which in turn reduces the pressure on blood vessel walls. Chlorthalidone is noted for its long-acting effect and has been shown to be effective in reducing the risk of cardiovascular events and heart failure when used for hypertension management. TELMISTRUM CH 40 can offer a more effective approach for lowering blood pressure than either medication alone. The combination targets different physiological mechanisms—Telmisartan relaxes blood vessels, while Chlorthalidone reduces blood volume through its diuretic effect. This dual action can be particularly beneficial for patients whose blood pressure is not adequately controlled with monotherapy. Considerations and Side Effects Side Effects: Common side effects of Telmisartan include dizziness, fatigue, and back pain, while Chlorthalidone may cause dehydration, electrolyte imbalances, and increased urination. It's important to monitor for signs of electrolyte imbalance, such as weakness, dry mouth, thirst, or muscle cramps. Monitoring: Patients on this combination therapy should have their blood pressure regularly monitored, along with periodic checks for kidney function and electrolyte levels, especially potassium and sodium. Lifestyle Changes: Combining medication with lifestyle modifications—such as a balanced diet low in sodium, regular physical activity, moderation in alcohol consumption, and smoking cessation—can further improve blood pressure control and overall cardiovascular health. For further information: EMAIL: info@sterispharma.com / contact@sterispharma.com CALL/WHATSAPP: 7877551268, 7849827488 BUY NOW https://www.sterisonline.com/product/telmistrum-ch-40-133380
